VitaNova Life Sciences Corp

VitaNova Life Sciences Corporation (VNOV)

Overview

VitaNova Life Sciences Corporation is a U.S.-focused consumer health, beauty, and lifestyle company that develops, acquires, markets, and sells branded nutritional supplements, functional beverages, and related lifestyle products. The company operates an asset-light model: product strategy, formulation oversight, brand management, and regulatory compliance are handled in-house, while production, packaging, and fulfillment are performed by third-party contract manufacturers and logistics partners.

VitaNova uses a dual-brand strategy:

• GeneCode® — science-oriented wellness formulations with ingredient-level information and internal formulation review; products are not clinically tested and are not intended to diagnose, treat, cure, or prevent disease.
• AMZ® — a functional-nutrition line for everyday support, positioned for price-sensitive, mass-market channels and marketed under the same regulatory framework as GeneCode.

Primary go-to-market channels include B2B partnerships with regional distributors and channel partners, diversified online traffic channels (Douyin Cross-border, Weidian Cross-border), direct-to-consumer sales in the United States, livestreaming and influencer collaborations, online marketing, and selective offline partnerships with wellness providers and distributors. In July 2021 the company began offering business consulting services related to funding and financial matters. In 2026 VitaNova launched a healthy foods product line under VitaNova Global Foods Corporation (VGFC).

Corporate history and structure

• Incorporated January 25, 2017 in Nevada (originally Soldino Group Corp.; renamed Yijia Group Corp. on January 15, 2018; renamed VitaNova Life Sciences Corporation in January 2026; ticker VNOV following the January 2026 rename).
• Subsidiaries:
  • NutriPeak Trading Corporation (NTC): wholly owned; established November 2023 to market and supply dietary supplement products; operations have been consolidated through NTC since November 2023.
  • VitaNova Global Foods Corporation (VGFC): wholly owned; formed March 6, 2026 to market and supply healthy food products.
• Capital structure updates:
  • November 2025: authorized shares increased to 210,000,000 (200,000,000 Common; 10,000,000 blank-check Preferred) and designation of 3,000,000 Series A Preferred shares.
  • January 27, 2026: completed a 1-for-3 reverse stock split.

Products and market position

• Two-tier product strategy: an advanced, science-oriented line (GeneCode®) focused on cellular and cognitive wellness, and a mass-market line (AMZ®) designed for high-velocity e-commerce and marketplace channels.
• Product development relies on internal review of publicly available research, supplier technical information, and general nutritional frameworks. Claims are framed as general wellness or support of normal physiological functions; finished products have not undergone clinical trials.
• In 2026, VGFC introduced new healthy food products (olive juice, white sesame oil, aloe vera drinks, and similar items) to broaden revenue sources beyond dietary supplements.

Regulatory and compliance

• The company operates within the FDA and DSHEA framework for dietary supplements, with attention to new dietary ingredient notifications (NDINs) and ingredient safety. The company monitors NDIN guidance issued by the FDA in 2024.
• Compliance practices include vetting ingredients for NDIN and GRAS status where applicable, ensuring cGMP compliance for manufacturing, aligning with FSMA and Foreign Supplier Verification Program (FSVP) requirements for importers, and addressing food traceability requirements under the FDA’s Food Traceability Rule.
• Supplier onboarding includes quality agreements, warranties, and insurance where possible.
• Advertising and product claims are subject to FTC standards for truthfulness and substantiation; claims are supported by competent and reliable scientific evidence at publication.

Operations and infrastructure

• Principal executive offices: 39 E Broadway, Suite 603, New York, NY 10002.
• Storage facility: approximately 700 square feet leased in Babylon, New York on a month-to-month basis.
• Employees: 7 full-time employees as reported in the most recent Annual Report.
• Intellectual property and brand management are centralized under the corporate governance structure, with internal regulatory and product-development teams overseeing formulation and claims management.

Customers and revenue

• The company emphasizes B2B partnerships and cross-border/digital channels as core revenue drivers, and it plans a subscription platform to improve retention and recurring revenue.
• VGFC generated meaningful revenue shortly after its product launches in the fiscal year ended April 30, 2026.

Key risks and considerations

• The industry is large, fragmented, and highly competitive.
• Reliance on third-party manufacturers and distributors creates supply-chain and quality-control exposure.
• Regulatory actions or failures to meet cGMP, FSMA, or NDIN requirements could affect product eligibility, labeling, or marketing claims.
• The company lacked certain insurance coverages at the time of the report (including product liability, clinical trial, key person, and business interruption) and is pursuing appropriate coverage.
• Cybersecurity and data protection are potential risks due to reliance on third-party vendors and cloud platforms.

Additional information

• VitaNova is a reporting issuer under the Exchange Act; filings are available through the SEC.
• The company operates a multi-brand framework and aims to grow through online channels, distribution partnerships, and expansion into healthy-food products through VGFC.